• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉波达辛和佐利弗达辛如何与细菌IIA型拓扑异构酶稳定DNA切割复合物?2. 单一移动金属机制。

How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism.

作者信息

Nicholls Robert A, Morgan Harry, Warren Anna J, Ward Simon E, Long Fei, Murshudov Garib N, Sutormin Dmitry, Bax Benjamin D

机构信息

Scientific Computing Department, UKRI Science and Technology Facilities Council, Harwell Campus, Didcot, Oxfordshire OX11 0DE, UK.

Medicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.

出版信息

Int J Mol Sci. 2024 Dec 24;26(1):33. doi: 10.3390/ijms26010033.

DOI:10.3390/ijms26010033
PMID:39795899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11720246/
Abstract

DNA gyrase is a bacterial type IIA topoisomerase that can create temporary double-stranded DNA breaks to regulate DNA topology and an archetypical target of antibiotics. The widely used quinolone class of drugs use a water-metal ion bridge in interacting with the GyrA subunit of DNA gyrase. Zoliflodacin sits in the same pocket as quinolones but interacts with the GyrB subunit and also stabilizes lethal double-stranded DNA breaks. Gepotidacin has been observed to sit on the twofold axis of the complex, midway between the two four-base-pair separated DNA-cleavage sites and has been observed to stabilize singe-stranded DNA breaks. Here, we use information from three crystal structures of complexes of DNA gyrase (one with a precursor of gepotidacin and one with the progenitor of zoliflodacin) to propose a simple single moving metal-ion-catalyzed DNA-cleavage mechanism. Our model explains why the catalytic tyrosine is in the tyrosinate (negatively charged) form for DNA cleavage. Movement of a single catalytic metal-ion (Mg or Mn) guides water-mediated protonation and cleavage of the scissile phosphate, which is then accepted by the catalytic tyrosinate. Type IIA topoisomerases need to be able to rapidly cut the DNA when it becomes positively supercoiled (in front of replication forks and transcription bubbles) and we propose that the original purpose of the small Greek Key domain, common to all type IIA topoisomerases, was to allow access of the catalytic metal to the DNA-cleavage site. Although the proposed mechanism is consistent with published data, it is not proven and other mechanisms have been proposed. Finally, how such mechanisms can be experimentally distinguished is considered.

摘要

DNA促旋酶是一种细菌IIA型拓扑异构酶,可产生临时双链DNA断裂以调节DNA拓扑结构,也是抗生素的典型作用靶点。广泛使用的喹诺酮类药物通过水-金属离子桥与DNA促旋酶的GyrA亚基相互作用。佐利氟达辛与喹诺酮类药物位于同一口袋中,但与GyrB亚基相互作用,还能稳定致死性双链DNA断裂。已观察到吉波达辛位于复合物的二重轴上,在两个相隔四个碱基对的DNA切割位点之间的中间位置,并且已观察到它能稳定单链DNA断裂。在此,我们利用来自DNA促旋酶复合物的三种晶体结构的信息(一种与吉波达辛的前体形成复合物,一种与佐利氟达辛的祖代形成复合物)提出一种简单的单移动金属离子催化的DNA切割机制。我们的模型解释了为什么催化酪氨酸在DNA切割时处于酪氨酸盐(带负电荷)形式。单个催化金属离子(镁或锰)的移动引导水介导的质子化和可切割磷酸酯的切割,然后被催化酪氨酸盐接受。IIA型拓扑异构酶需要能够在DNA变为正超螺旋时(在复制叉和转录泡前方)快速切割DNA,我们提出所有IIA型拓扑异构酶共有的小希腊钥匙结构域的最初目的是允许催化金属进入DNA切割位点。尽管所提出的机制与已发表的数据一致,但尚未得到证实,也有人提出了其他机制。最后,考虑了如何通过实验区分这些机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/bcd3ee57023f/ijms-26-00033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/cef33bcd0981/ijms-26-00033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/b53f94ae4c78/ijms-26-00033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/e8eb335f30ab/ijms-26-00033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/d605a0b31293/ijms-26-00033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/e7b7477893a3/ijms-26-00033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/54a39353a832/ijms-26-00033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/bcd3ee57023f/ijms-26-00033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/cef33bcd0981/ijms-26-00033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/b53f94ae4c78/ijms-26-00033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/e8eb335f30ab/ijms-26-00033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/d605a0b31293/ijms-26-00033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/e7b7477893a3/ijms-26-00033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/54a39353a832/ijms-26-00033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c437/11720246/bcd3ee57023f/ijms-26-00033-g006.jpg

相似文献

1
How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism.吉波达辛和佐利弗达辛如何与细菌IIA型拓扑异构酶稳定DNA切割复合物?2. 单一移动金属机制。
Int J Mol Sci. 2024 Dec 24;26(1):33. doi: 10.3390/ijms26010033.
2
How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites.Gepotidacin 和 Zoliflodacin 如何稳定与细菌 IIA 拓扑异构酶结合的 DNA 断裂复合物?1. 金属结合位点的实验定义。
Int J Mol Sci. 2024 Oct 30;25(21):11688. doi: 10.3390/ijms252111688.
3
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.抗菌药物格帕沙星作用于金黄色葡萄球菌促旋酶的作用机制及结构基础
ACS Infect Dis. 2019 Apr 12;5(4):570-581. doi: 10.1021/acsinfecdis.8b00315. Epub 2019 Feb 28.
4
A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with DNA Gyrase.佐利福定与 DNA 拓扑异构酶形成的 DNA 切割复合物的 2.8 Å 结构。
Int J Mol Sci. 2023 Jan 13;24(2):1634. doi: 10.3390/ijms24021634.
5
DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion.DNA 拓扑异构酶抑制剂:捕获运动中的 DNA 切割机器。
J Mol Biol. 2019 Aug 23;431(18):3427-3449. doi: 10.1016/j.jmb.2019.07.008. Epub 2019 Jul 10.
6
Interactions between Zoliflodacin and Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting.唑利福定与拓扑异构酶 II 和拓扑异构酶 IV 的相互作用:细胞靶向的酶学基础。
ACS Infect Dis. 2024 Aug 9;10(8):3071-3082. doi: 10.1021/acsinfecdis.4c00438. Epub 2024 Jul 31.
7
Type IIA topoisomerase inhibition by a new class of antibacterial agents.新型抗菌药物对 IIA 拓扑异构酶的抑制作用。
Nature. 2010 Aug 19;466(7309):935-40. doi: 10.1038/nature09197. Epub 2010 Aug 4.
8
Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin.抗菌药物QPT-1、抗癌药物依托泊苷和莫西沙星对DNA回旋酶抑制作用的结构基础。
Nat Commun. 2015 Dec 7;6:10048. doi: 10.1038/ncomms10048.
9
Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV.基于萘啶酮/氨基哌啶的抗菌药物的双重作用模式,该药物靶向拓扑异构酶 II 和拓扑异构酶 IV。
Biochemistry. 2019 Nov 5;58(44):4447-4455. doi: 10.1021/acs.biochem.9b00805. Epub 2019 Oct 28.
10
Interactions between Gepotidacin and Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting.Gepotidacin 与拓扑异构酶 IV 和拓扑异构酶 V 的相互作用:双重靶向平衡的遗传和生化证据。
ACS Infect Dis. 2024 Apr 12;10(4):1137-1151. doi: 10.1021/acsinfecdis.3c00346. Epub 2024 Mar 5.

引用本文的文献

1
Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors.非典型细菌拓扑异构酶抑制剂的结构与作用机制洞察
ACS Med Chem Lett. 2025 Apr 1;16(4):660-667. doi: 10.1021/acsmedchemlett.5c00060. eCollection 2025 Apr 10.

本文引用的文献

1
Structural basis of chiral wrap and T-segment capture by DNA gyrase.DNA 拓扑异构酶对手性包裹和 T 段捕获的结构基础。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2407398121. doi: 10.1073/pnas.2407398121. Epub 2024 Nov 26.
2
How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites.Gepotidacin 和 Zoliflodacin 如何稳定与细菌 IIA 拓扑异构酶结合的 DNA 断裂复合物?1. 金属结合位点的实验定义。
Int J Mol Sci. 2024 Oct 30;25(21):11688. doi: 10.3390/ijms252111688.
3
Interactions between Gepotidacin and Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting.
Gepotidacin 与拓扑异构酶 IV 和拓扑异构酶 V 的相互作用:双重靶向平衡的遗传和生化证据。
ACS Infect Dis. 2024 Apr 12;10(4):1137-1151. doi: 10.1021/acsinfecdis.3c00346. Epub 2024 Mar 5.
4
Structural basis of DNA crossover capture by DNA gyrase.DNA 拓扑异构酶捕获 DNA 交叉的结构基础。
Science. 2024 Apr 12;384(6692):227-232. doi: 10.1126/science.adl5899. Epub 2024 Apr 11.
5
The interaction between transport-segment DNA and topoisomerase IA-crystal structure of MtbTOP1 in complex with both G- and T-segments.结核分枝杆菌拓扑异构酶 IA 与 G-和 T-片段复合物的晶体结构中,转运片段 DNA 与拓扑异构酶 IA 的相互作用。
Nucleic Acids Res. 2023 Jan 11;51(1):349-364. doi: 10.1093/nar/gkac1205.
6
Hydrogens and hydrogen-bond networks in macromolecular MicroED data.大分子微电子衍射数据中的氢原子与氢键网络
J Struct Biol X. 2022 Nov 10;6:100078. doi: 10.1016/j.yjsbx.2022.100078. eCollection 2022.
7
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
8
Tyrosine 121 moves revealing a ligandable pocket that couples catalysis to ATP-binding in serine racemase.酪氨酸 121 移动揭示了一个可配体的口袋,它将催化与丝氨酸消旋酶的 ATP 结合偶联起来。
Commun Biol. 2022 Apr 11;5(1):346. doi: 10.1038/s42003-022-03264-5.
9
Human topoisomerases and their roles in genome stability and organization.人类拓扑异构酶及其在基因组稳定性和组织中的作用。
Nat Rev Mol Cell Biol. 2022 Jun;23(6):407-427. doi: 10.1038/s41580-022-00452-3. Epub 2022 Feb 28.
10
Mechanism of Type IA Topoisomerases.IA 型拓扑异构酶的作用机制。
Molecules. 2020 Oct 17;25(20):4769. doi: 10.3390/molecules25204769.